Découvrez nos professeurs et professeures!
Marie-Claude Pelland-Marcotte
Médecin clinicienne enseignante sous octroi adjointe
Contribution à la recherche
Projets de recherche
- Impact clinique et prédiction précoce de la thrombo-embolie veineuse chez l'enfant atteint de cancer - Fonds de recherche du Québec - Santé - Chercheurs-boursiers cliniciens - Juniors 1 et 2, Seniors, chercheur principal - 2023-07-01 au 2027-06-30
- Impact clinique et prediction precoce de la thrombo-embolie veineuse chez l'enfant atteint de cancer- Subvention établissement de jeunes chercheurs - Fonds de recherche du Québec - Santé - Établissement de jeunes chercheurs - Juniors 1, chercheur principal - 2023-04-01 au 2027-03-31
- Biomarkers for prediction of venous thrombo-embolism in children with cancer - CHU de Québec – Université Laval – CHUL - Subvention en recherche clinique (PCRE), chercheur principal - 2024-01-23 au 2024-12-31
- Thrombose liée aux voies veineuses centrales dans la population néonatale : une étude observationnelle multicentrique - Fondation du CHU de Québec - Subvention en recherche clinique (PCRE), chercheur principal - 2023-04-01 au 2024-03-31
- Anticoagulation for venous thrombosis in children with obesity - Canadian Pediatric Thrombosis & Hemostasis Network, chercheur principal - 2023-04-24 au 2024-03-31
- Influence de l’environnement leucémique dans le développement d’évènements thrombotiques chez les enfants atteints de leucémie lymphoblastique aigue traités dans l’essai thérapeutique international prospectif DFCI 16-001 - CHU de Québec – Université Laval – CHUL - Subvention de fonctionnement de centre, co-chercheur - 2023-02-21 au 2024-03-31
- Bourses de recherche Pierre-Déry du Département de pédiatrie - Fondation de l'Université Laval, chercheur principal - 2020-01-01 au 2024-03-31
- Clinical significance and natural history of clinically unsuspected central venous catheter-related thrombosis in children with cancer - Instituts de recherche en santé du Canada - Subvention Projet, chercheur principal - 2023-03-01 au 2024-02-29
- Étude pilote sur l'histoire naturelle des thromboses asymptomatiques sur cathéters veineux centraux chez les enfants atteints de cancer - Fondation du CHU de Québec, CHU de Québec – Université Laval – CHUL - Aide à la recherche, chercheur principal - 2022-09-16 au 2023-09-15
- Fonds de démarrage. Marie-Claude Pelland-Marcotte - CHU de Québec – Université Laval – CHUL - Fonds de démarrage, chercheur principal - 2020-01-01 au 2021-12-31
Publications
- Levofloxacin prophylaxis in hospitalized children with leukemia: A cost‐utility analysis, Lillian Sung, Sumit Gupta, Sarah Alexander, Marie‐Claude Pelland‐Marcotte, Brandon Maser, Pediatric Blood & Cancer, 2020, 10.1002/pbc.28643
- Severe infections following treatment for childhood cancer: a report from CYP-C, Lillian Sung, Rinku Sutradhar, Paul C. Nathan, Jason D. Pole, Marie-Claude Pelland-Marcotte, Leukemia & Lymphoma, 2020, 10.1080/10428194.2020.1789626
- Rivaroxaban for Management of Venous Thromboembolism in Pediatric Nephrotic Syndrome; a Case Report and Review of Literature, Ali Amid, Karen Lyons, Cherry Mammen, Jessica Halparin, Susan Lee, Eve Bouhelier, Soumitra Tole, Marie-Claude Pelland-Marcotte, Pediatric Hematology and Oncology, 2023, 10.1080/08880018.2022.2150797
- Clinical characteristics and outcomes of SARS‐CoV‐2 infection in pediatric oncology patients in the province of Quebec, Thai Hoa Tran, Raoul Santiago, Marie‐Claude Pelland‐Marcotte, Catherine Vézina, Josée Brossard, Samuel Bérubé, Jessica Liu, Amalia M. Souza, Nawar Dakhallah, André P. Ilinca, Pediatric Blood & Cancer, 2022, 10.1002/pbc.29572
- COVID‐19‐associated coagulopathy in children: A multicenter observational cohort study, Christine Sabapathy, Marie‐Claude Pelland‐Marcotte, Janie Charlebois, Rochelle Winikoff, Alexandra Zabeida, Pediatric Blood & Cancer, 2023, 10.1002/pbc.30079
- Effectiveness and Safety of Primary Thromboprophylaxis in Children with Cancer: A Systematic Review of the Literature and Network Meta-Analysis, Leonardo Rodrigues Brandão, Petros Pechlivanoglou, Soumitra Tole, Marie-Claude Pelland-Marcotte, Thrombosis and Haemostasis, 2019, 10.1055/s-0039-1697027
- Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children, Manuel D. Carcao, Mackenzie L. Bowman, Janette T. Reyes, Vanessa Bouskill, Margaret L. Rand, Paula D. James, Tilman Humpl, Marie‐Claude Pelland‐Marcotte, British Journal of Haematology, 2018, 10.1111/bjh.15530
- A novel FGG missense variant associated with fibrinogen storage disease in a large family from Quebec, Georges‐Etienne Rivard, Alessandro Casini, Marguerite Neerman‐Arbez, Julie Gauthier, Julie Castilloux, Christine Demers, Hélène Néron, Adelina‐Teona Avram, Marie‐Claude Pelland‐Marcotte, Haemophilia, 2024, 10.1111/hae.15006
- Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP‐C, Lillian Sung, Leonardo R. Brandão, Jason D. Pole, Uma H. Athale, Marie‐Claude Pelland‐Marcotte, Ketan Kulkarni, American Journal of Hematology, 2021, 10.1002/ajh.26193
- Post‐procedural bleeding rate and haemostatic treatment use for dental procedures before and after the implementation of a standardized protocol for people with inherited bleeding disorders, Marie‐Claude Pelland‐Marcotte, Hélène Néron, Narcisse Ulrich Singbo, Stéphanie Cloutier, Christine Demers, Marie‐Pier Desjardins, Michelle Bourassa, Pier‐Ann Champagne, Haemophilia, 2022, 10.1111/hae.14609
- Distance to the pediatric oncology center does not affect survival in children with acute lymphoblastic leukemia: a report from CYP-C, Bruno Michon, Émilie Martineau, Barbara Desbiens, David Simonyan, Marie-Claude Pelland-Marcotte, Daphné Lemieux-Sarrasin, Leukemia & Lymphoma, 2021, 10.1080/10428194.2020.1849673
- Clinical characteristics and outcomes of SARS-CoV-2 infection in pediatric oncology patients in the province of Quebec, Thai Hoa Tran, Raoul Santiago, Marie-Claude Pelland-Marcotte, Catherine Vezina, Josee Brossard, Samuel Bérubé, Jessica Liu, Amalia Souza, Nawar Dakhallah, André Ilinca, 2024, 10.22541/au.170669435.59625011/v1
- Incidence of infections after therapy completion in children with acute lymphoblastic leukemia or acute myeloid leukemia: a systematic review of the literature, Lillian Sung, Paul C. Nathan, Jason D. Pole, Jeremiah Hwee, Marie-Claude Pelland-Marcotte, Leukemia & Lymphoma, 2019, 10.1080/10428194.2019.1573369
- French Canadian cross-cultural adaptation of CAPTSure©, an index for the Clinical Assessment of Post-Thrombotic Syndrome in children, Laura Avila, Raoul Santiago, Gina Wong, Angelika Stavrakoukas, Marie-Claude Pelland-Marcotte, Journal of Patient-Reported Outcomes, 2023, 10.1186/s41687-023-00622-7
- Rivaroxaban for management of venous thromboembolism in pediatric nephrotic syndrome; a case report and review of literature, Ali Amid, Karen Lyons, Cherry Mammen, Jessica Halparin, Susan Lee, Eve Bouhelier, Marie-Claude Pelland-Marcotte, Soumitra Tole, 2022, 10.22541/au.164949123.38497885/v1
- Update: Clinical characteristics and outcomes of SARS‐CoV‐2 infection in pediatric oncology patients in the province of Quebec, Thai Hoa Tran, Marie‐Claude Pelland‐Marcotte, Raoul Santiago, Catherine Vézina, Josée Brossard, Samira Mezziani, Marie‐Ève Leclerc, Amalia M. Souza, Nawar Dakhallah, André P. Ilinca, Pediatric Blood & Cancer, 2023, 10.1002/pbc.29936
- Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from CYP‐C, Uma H. Athale, Lillian Sung, Sumit Gupta, David Stammers, Thai Hoa Tran, Ketan Kulkarni, Marie‐Claude Pelland‐Marcotte, American Journal of Hematology, 2024, 10.1002/ajh.27171
- VERY EARLY DIAGNOSIS AND MANAGEMENT OF CONGENITAL ERYTHROPOIETIC PORPHYRIA AT BIRTH, Marie-Claude Pelland-Marcotte, Pierre Teira, Isabelle Auger, Audrey Hébert, Lamia Naccache, Marie-Pier Desjardins, 2024, 10.22541/au.170665855.54975829/v1